TLSIW 8-K 2026-11-10

TriSalus Life Sciences, Inc. (TLSIW) 8-K dated 2026-11-10 — accession 0001628280-26-072513.

TriSalus Life Sciences, Inc. (TLSIW) warrant listed on NASDAQ.

TLSIW revenue $12.9M

This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported TLSIW revenue for 2025-12-31 was $45.2M. Net income was -$39.2M. Revenue was up 53.4% from 2024-12-31 to 2025-12-31.

Not investment advice. The TLSIW SEC hub lists recent forms. The stock page is the research view.